Category - Executive Moves

Executive Moves

Medtech analyst Raj Denhoy joins Establishment Labs as head of strategy, IR

Establishment Labs Holdings (NASDAQ: ESTA) appointed Raj Denhoy as head of strategy and investor relations to help define and execute the company’s corporate strategy and communicate that vision to investors and other...

March 3, 2021

Executive Moves

Profound Medical appoints healthcare investment professional Cynthia Lavoie to board

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed seasoned healthcare investment professional Cynthia Lavoie, Ph.D., to the board of the commercial-stage medical device company that develops and markets customizable...

March 3, 2021

Executive Moves

Nurx names telehealth pioneer Jennifer Peña as CMO

Nurx, a telehealth platform providing convenient and affordable care for female health needs, appointed Dr. Jennifer Peña, M.D., as chief medical officer to help Nurx build on a record year of growth and begin treating...

March 1, 2021

Executive Moves

PYC Therapeutics adds industry veteran Glenn Noronha as CDO

Glenn Noronha, PhD, has joined PYC Therapeutics (ASX:PYC) as chief development officer to oversee the company’s translational clinical development, regulatory, manufacturing and preclinical development activities as it...

February 23, 2021

Executive Moves

iBio appoints accomplished financial executive Robert Lutz as CFBO

iBio (NYSE American:iBio) appointed Robert Lutz as chief financial and business officer (CFBO), effective March 4, 2021. Mr. Lutz will lead iBio’s finance organization and be responsible for building strong licensing...

February 16, 2021

Executive Moves

Hepion names renowned clinician Dr. Todd Hobbs as CMO

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Todd Hobbs, M.D., to the newly created position of chief medical officer, effective Feb. 16, 2021. In this role, Dr. Hobbs will help lead Hepion as it engages with the FDA...

February 10, 2021

Executive Moves

PharmaJet names Marian Wentworth to board

Closely-held PharmaJet appointed Marian Wentworth, president and CEO of Management Sciences for Health since 2017, to its board. Management Sciences for Health is a non-profit organization that works with low- and...

February 9, 2021

Executive Moves

Jim Lilly joins England & Co. in healthcare investment banking

Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

January 19, 2021

Executive Moves

Justin Zelin joins BTIG as biotech analyst

BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology, immunology and...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been with...

January 13, 2021

Category - Executive Moves

Medtech analyst Raj Denhoy joins Establishment Labs as head of strategy, IR

Profound Medical appoints healthcare investment professional Cynthia Lavoie to board

Nurx names telehealth pioneer Jennifer Peña as CMO

PYC Therapeutics adds industry veteran Glenn Noronha as CDO

iBio appoints accomplished financial executive Robert Lutz as CFBO

Hepion names renowned clinician Dr. Todd Hobbs as CMO

PharmaJet names Marian Wentworth to board

Jim Lilly joins England & Co. in healthcare investment banking

Justin Zelin joins BTIG as biotech analyst

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

General

More